Immunotherapy Consolidation After Radical Treatment of Synchronous Oligo-metastatic NSCLC
Clinical trial NCT06219317 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06219317
- Sponsor
- European Organisation for Research and Treatment of Cancer - EORTC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-14
- Primary completion
- 2030-01-01
- Enrollment
- 136
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.